Nationwide Outcomes and Predictors of Mortality After Left Ventricular Assist Device Implantation in Korea ― Insights From the Korean Registry for Mechanically Assisted Circulatory Support ―
Background: Durable left ventricular assist device (LVAD) therapy was introduced in Korea in 2018 within a transplant environment characterized by frequent preoperative extracorporeal membrane oxygenation (ECMO) support. We evaluated nationwide outcomes and predictors of mortality after LVAD implantation.
Authors
- Chisoo Park
- Eung Joong Kim
- Yoon Jung Choi (ORCID: https://orcid.org/0000-0001-7571-2908)
- Jong Youn Moon (ORCID: https://orcid.org/0000-0001-5278-6816)
- 김지혜
- Sun Hyun Moon
- Jong‐Chan Youn (ORCID: https://orcid.org/0000-0003-0998-503X)
- Keon Hyun Jo
- Hyun-Jai Cho
- Su-Jin Cho
- Young Hwan Park
- Yang Hyun Cho
Institutions
- Gachon University (KR)
- Samsung Medical Center (KR)
- Seoul National University Hospital (KR)
- St. Mary's Hospital (US)
- Health Insurance Review and Assessment Service (KR)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Circulation Reports
- Published
- 2026-09-14
- DOI
- https://doi.org/10.1253/circrep.cr-26-0201
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Research Foundation
- Health Insurance Review and Assessment Service
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea